Ibuprofene Olympe Pharma

Ibuprofen, the active ingredient in Ibuprofene Olympe Pharma, is a nonsteroidal anti‑inflammatory drug presented as an oral tablet (strength not specified) for oral use. It treats mild to moderate pain, fever, and inflammatory conditions in adults and children when appropriate.

GNH USA supplies Ibuprofene Olympe Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand across Europe, Asia and the Americas.

Ibuprofen, a nonsteroidal anti‑inflammatory drug, is indicated for conditions involving pain, fever, or inflammation. - Headache: Reduces pain intensity and associated discomfort. - Dental pain: Alleviates postoperative or acute toothache. - Musculoskeletal pain: Improves mobility by decreasing inflammation in joints and muscles. - Fever: Lowers elevated body temperature in acute febrile states. - Arthritis (including osteoarthritis and rheumatoid arthritis): Provides symptomatic relief of joint pain and swelling.

Like all NSAIDs, ibuprofen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or mild abdominal pain. - Headache: transient headache episodes. - Dizziness: light‑headedness or vertigo. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: may present as black stools or vomiting blood. - Renal impairment: reduced kidney function or acute kidney injury. - Hepatotoxicity: elevated liver enzymes or jaundice. - Cardiovascular events: increased risk of heart attack or stroke, especially with high‑dose or prolonged use. - Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome.

When prescribing ibuprofen, clinicians should evaluate patient history and monitor for potential risks. - Assess renal function: avoid use in patients with severe kidney disease. - Evaluate gastrointestinal risk: consider gastro‑protective agents for those with a history of ulcers. - Review cardiovascular status: use caution in patients with hypertension or heart disease. - Monitor liver enzymes: especially in patients with existing hepatic impairment. - Avoid use in late pregnancy: NSAIDs are contraindicated in the third trimester. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Ibuprofen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - High‑dose aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function. - Lithium: ibuprofen can raise lithium serum levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in diuretic efficacy and renal perfusion. - Methotrexate: decreased clearance leading to toxicity. - Cyclosporine: increased nephrotoxic risk. - Corticosteroids: synergistic risk of gastrointestinal ulceration. - Oral hypoglycemics: may enhance hypoglycemic effect.